Eledon Pharmaceuticals (ELDN) vs Cartesian Therapeutics (RNAC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Eledon Pharmaceuticals (ELDN) has outperformed Cartesian Therapeutics (RNAC) over the past year, losing 11.4% versus a loss of 31.4%. Over five years, ELDN leads with a -57.0% price change compared with -94.8% for RNAC. Cartesian Therapeutics is the larger company by market cap ($202.1 million vs $196.7 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELDN | RNAC |
|---|---|---|
| Share price | $2.42 | $6.68 |
| Market cap | $196.65M | $202.11M |
| 1-day change | -1.22% | -1.04% |
| YTD return | +60.26% | -7.35% |
| 1-year return | -11.36% | -31.42% |
| 5-year return | -57.02% | -94.79% |
| EPS (TTM) | $-0.90 | $-5.78 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.60 | $11.00 |
| 52-week low | $1.35 | $5.60 |
| Distance from 52-week high | -47.39% | -39.27% |
| Average volume | 969.03K | 133.29K |
| Shares outstanding | 81.26M | 30.26M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELDN has outperformed RNAC by 20.1 percentage points over the past year.
ELDN vs RNAC FAQ
Which is bigger, Eledon Pharmaceuticals or Cartesian Therapeutics?
Cartesian Therapeutics (RNAC) is larger, with a market capitalization of $202.11M compared with $196.65M for Eledon Pharmaceuticals (ELDN).
Which stock has performed better over the past year, ELDN or RNAC?
ELDN returned -11.36% over the past 12 months, compared with -31.42% for RNAC (price return, excluding dividends). Past performance does not predict future results.
Are Eledon Pharmaceuticals and Cartesian Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.